Alpha-Maven Private Equity Dashboard:

Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

2w ago Private Equity privateequitywire Views: 131

Hanover Investors appoints Senior Partner Submitted 02/09/2021 - 10:59am Hanover Investors, a special situations specialist, is appointing John Woodard as a Senior Partner. Woodard has spent more than 25 years in the private equity industry in positions spanning Credit Suisse First Boston, Wesray Capital Corporation, The Blackstone Group and Vestar Capital Partners, where he led the Industrial practice, served on the investment committee and spent three years in Japan running Asian operations. He joins the firm with immediate effect as part of the leadership team as well as having a key role in the Hanover Active Equity Fund II (HAEF II) and future successor funds. The HAEF strategy deploys proprietary, data-led research to identify complex stakeholder situations and under-researched businesses with excellent value potential for a control investor. While Woodard is moving into an executive role, he has been on the firm’s investment committee for a number of years and is the Chairman of Escher and ClearStar, two of Hanover’s portfolio companies. Matthew Peacock, Founder and Chairman of Hanover Investors, says: “I have known John for more than 30 years, through both working and investing together. He is a first-class operator and his arrival adds to our bench strength as we continue to deliver superior returns for our investors. It is another signal of our intent to develop and grow our investment capabilities.” Woodard has significant international experience and has also served on boards including Duff & Phelps, Solo Cup, Hampshire Chemical, and Argo-Tech. Woodard says: “I know Hanover Investors very well, having worked closely with Matthew and the team over the years. It has both world class talent and an investment approach which is relentlessly focused on unlocking value and catalysing growth. I am delighted to be joining at this juncture in the firm’s trajectory.” Like this article? Sign up to our free newsletter Author Profile Related Topics Moves & Appointments -

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.